Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 99

1.

Clinical and Laboratory Development of Echinocandin Resistance in Candida glabrata: Molecular Characterization.

Rivero-Menendez O, Navarro-Rodriguez P, Bernal-Martinez L, Martin-Cano G, Lopez-Perez L, Sanchez-Romero I, Perez-Ayala A, Capilla J, Zaragoza O, Alastruey-Izquierdo A.

Front Microbiol. 2019 Jul 11;10:1585. doi: 10.3389/fmicb.2019.01585. eCollection 2019.

2.

EUCAST Reference Testing of Rezafungin Susceptibility and Impact of Choice of Plastic Plates.

Arendrup MC, Jørgensen KM, Hare RK, Cuenca-Estrella M, Zaragoza O.

Antimicrob Agents Chemother. 2019 Aug 23;63(9). pii: e00659-19. doi: 10.1128/AAC.00659-19. Print 2019 Sep.

PMID:
31285230
3.

Basic principles of the virulence of Cryptococcus.

Zaragoza O.

Virulence. 2019 Dec;10(1):490-501. doi: 10.1080/21505594.2019.1614383.

4.

Identification of Off-Patent Compounds That Present Antifungal Activity Against the Emerging Fungal Pathogen Candida auris.

de Oliveira HC, Monteiro MC, Rossi SA, Pemán J, Ruiz-Gaitán A, Mendes-Giannini MJS, Mellado E, Zaragoza O.

Front Cell Infect Microbiol. 2019 Apr 2;9:83. doi: 10.3389/fcimb.2019.00083. eCollection 2019.

5.

Detection and treatment of Candida auris in an outbreak situation: risk factors for developing colonization and candidemia by this new species in critically ill patients.

Ruiz-Gaitán A, Martínez H, Moret AM, Calabuig E, Tasias M, Alastruey-Izquierdo A, Zaragoza Ó, Mollar J, Frasquet J, Salavert-Lletí M, Ramírez P, López-Hontangas JL, Pemán J.

Expert Rev Anti Infect Ther. 2019 Apr;17(4):295-305. doi: 10.1080/14787210.2019.1592675. Epub 2019 Mar 29.

PMID:
30922129
6.

Immune Response of Galleria mellonella against Human Fungal Pathogens.

Trevijano-Contador N, Zaragoza O.

J Fungi (Basel). 2018 Dec 26;5(1). pii: E3. doi: 10.3390/jof5010003. Review.

7.

Discordant susceptibility of inbred C57BL/6 versus outbred CD1 mice to experimental fungal sepsis.

Carreras E, Velasco de Andrés M, Orta-Mascaró M, Simões IT, Català C, Zaragoza O, Lozano F.

Cell Microbiol. 2019 May;21(5):e12995. doi: 10.1111/cmi.12995. Epub 2019 Jan 9.

PMID:
30577088
8.

Characterization of the atypical Ppz/Hal3 phosphatase system from the pathogenic fungus Cryptococcus neoformans.

Zhang C, García-Rodas R, Molero C, de Oliveira HC, Tabernero L, Reverter D, Zaragoza O, Ariño J.

Mol Microbiol. 2019 Apr;111(4):898-917. doi: 10.1111/mmi.14181. Epub 2019 Mar 18.

PMID:
30536975
9.

Cryptococcal Titan Cells: When Yeast Cells Are All Grown up.

García-Rodas R, de Oliveira HC, Trevijano-Contador N, Zaragoza O.

Curr Top Microbiol Immunol. 2019;422:101-120. doi: 10.1007/82_2018_145. Review.

PMID:
30406867
10.

Cryptococcus neoformans can form titan-like cells in vitro in response to multiple signals.

Trevijano-Contador N, de Oliveira HC, García-Rodas R, Rossi SA, Llorente I, Zaballos Á, Janbon G, Ariño J, Zaragoza Ó.

PLoS Pathog. 2018 May 18;14(5):e1007007. doi: 10.1371/journal.ppat.1007007. eCollection 2018 May.

11.

Cryptococcal pathogenic mechanisms: a dangerous trip from the environment to the brain.

Esher SK, Zaragoza O, Alspaugh JA.

Mem Inst Oswaldo Cruz. 2018;113(7):e180057. doi: 10.1590/0074-02760180057. Epub 2018 Apr 16. Review.

12.

Multicentre determination of rezafungin (CD101) susceptibility of Candida species by the EUCAST method.

Arendrup MC, Meletiadis J, Zaragoza O, Jørgensen KM, Marcos-Zambrano LJ, Kanioura L, Cuenca-Estrella M, Mouton JW, Guinea J.

Clin Microbiol Infect. 2018 Nov;24(11):1200-1204. doi: 10.1016/j.cmi.2018.02.021. Epub 2018 Mar 2.

PMID:
29505881
13.

Capsule Enlargement in Cryptococcus neoformans Is Dependent on Mitochondrial Activity.

Trevijano-Contador N, Rossi SA, Alves E, Landín-Ferreiroa S, Zaragoza O.

Front Microbiol. 2017 Jul 31;8:1423. doi: 10.3389/fmicb.2017.01423. eCollection 2017.

14.

Candida guilliermondii Complex Is Characterized by High Antifungal Resistance but Low Mortality in 22 Cases of Candidemia.

Marcos-Zambrano LJ, Puig-Asensio M, Pérez-García F, Escribano P, Sánchez-Carrillo C, Zaragoza O, Padilla B, Cuenca-Estrella M, Almirante B, Martín-Gómez MT, Muñoz P, Bouza E, Guinea J.

Antimicrob Agents Chemother. 2017 Jun 27;61(7). pii: e00099-17. doi: 10.1128/AAC.00099-17. Print 2017 Jul.

15.

Evaluation of MALDI-TOF-MS for the Identification of Yeast Isolates Causing Bloodstream Infection.

Turhan O, Ozhak-Baysan B, Zaragoza O, Er H, Sarıtas ZE, Ongut G, Ogunc D, Colak D, Cuenca-Estrella M.

Clin Lab. 2017 Apr 1;63(4):699-703. doi: 10.7754/Clin.Lab.2016.161101.

PMID:
28397475
16.

Impact of fluconazole susceptibility on the outcome of patients with candidaemia: data from a population-based surveillance.

Fernández-Ruiz M, Guinea J, Lora-Pablos D, Zaragoza Ó, Puig-Asensio M, Almirante B, Cuenca-Estrella M, Aguado JM; CANDIPOP Project; GEIH-GEMICOMED (SEIMC) and REIPI.

Clin Microbiol Infect. 2017 Sep;23(9):672.e1-672.e11. doi: 10.1016/j.cmi.2017.01.014. Epub 2017 Jan 29.

17.

Twitter as a Tool for Teaching and Communicating Microbiology: The #microMOOCSEM Initiative.

López-Goñi I, Martínez-Viñas MJ, Antón J, Cid VJ, González AM, Brown-Jaque M, García-Lobo JM, Sánchez M, Vilchez JI, Robledo-Mahón T, Seder-Colomina M, Tapia-Paniagua ST, de Rojas AH, Mira A, Gallego-Parrilla JJ, Díaz TM, Maicas S, Villalobo E, Quindós G, Balboa S, Romalde JL, Aguilar-Pérez C, Tomás A, Linares M, Zaragoza Ó, Gil-Serna J, Ferrer-Espada R, Camacho AI, Vinué L, García-Lara J.

J Microbiol Biol Educ. 2016 Dec 2;17(3):492-494. doi: 10.1128/jmbe.v17i3.1200. eCollection 2016 Dec. No abstract available. Erratum in: J Microbiol Biol Educ. 2018 Jul 31;19(2):.

18.

Role of catalase overproduction in drug resistance and virulence in Candida albicans.

Román E, Prieto D, Martin R, Correia I, Mesa Arango AC, Alonso-Monge R, Zaragoza O, Pla J.

Future Microbiol. 2016 Oct;11:1279-1297. doi: 10.2217/fmb-2016-0067. Epub 2016 Oct 3.

PMID:
27690640
19.

Evaluation of the possible influence of trailing and paradoxical effects on the clinical outcome of patients with candidemia.

Rueda C, Puig-Asensio M, Guinea J, Almirante B, Cuenca-Estrella M, Zaragoza O; CANDIPOP Project from GEIH-GEMICOMED (SEIMC) and REIPI.

Clin Microbiol Infect. 2017 Jan;23(1):49.e1-49.e8. doi: 10.1016/j.cmi.2016.09.016. Epub 2016 Sep 24.

20.

New Panfungal Real-Time PCR Assay for Diagnosis of Invasive Fungal Infections.

Valero C, de la Cruz-Villar L, Zaragoza Ó, Buitrago MJ.

J Clin Microbiol. 2016 Dec;54(12):2910-2918. Epub 2016 Sep 14.

21.

Fungemia due to rare opportunistic yeasts: data from a population-based surveillance in Spain.

Fernández-Ruiz M, Guinea J, Puig-Asensio M, Zaragoza Ó, Almirante B, Cuenca-Estrella M, Aguado JM; CANDIPOP Project; GEIH-GEMICOMED (SEIMC) and REIPI.

Med Mycol. 2017 Feb 1;55(2):125-136. doi: 10.1093/mmy/myw055. Epub 2016 Aug 4.

PMID:
27495321
22.

Erratum for Marcos-Zambrano et al., Comparison between the EUCAST Procedure and the Etest for Determination of the Susceptibility of Candida Species Isolates to Micafungin.

Marcos-Zambrano LJ, Escribano P, Rueda C, Zaragoza Ó, Bouza E, Guinea J.

Antimicrob Agents Chemother. 2016 Jun 20;60(7):4429. doi: 10.1128/AAC.01090-16. Print 2016 Jul. No abstract available.

23.

Corrigendum: Impact of Resistance to Fluconazole on Virulence and Morphological Aspects of Cryptococcus neoformans and Cryptococcus gattii Isolates.

Rossi SA, Trevijano-Contador N, Scorzoni L, Mesa-Arango AC, de Oliveira HC, Werther K, de Freitas Raso T, Mendes-Giannini MJ, Zaragoza O, Fusco-Almeida AM.

Front Microbiol. 2016 Apr 22;7:537. doi: 10.3389/fmicb.2016.00537. eCollection 2016.

24.

Fungal morphogenetic changes inside the mammalian host.

Trevijano-Contador N, Rueda C, Zaragoza O.

Semin Cell Dev Biol. 2016 Sep;57:100-109. doi: 10.1016/j.semcdb.2016.04.008. Epub 2016 Apr 19. Review.

PMID:
27101887
25.

Biofilm Production and Antibiofilm Activity of Echinocandins and Liposomal Amphotericin B in Echinocandin-Resistant Yeast Species.

Marcos-Zambrano LJ, Gómez-Perosanz M, Escribano P, Zaragoza O, Bouza E, Guinea J.

Antimicrob Agents Chemother. 2016 May 23;60(6):3579-86. doi: 10.1128/AAC.03065-15. Print 2016 Jun.

26.

Impact of Resistance to Fluconazole on Virulence and Morphological Aspects of Cryptococcus neoformans and Cryptococcus gattii Isolates.

Rossi SA, Trevijano-Contador N, Scorzoni L, Mesa-Arango AC, de Oliveira HC, Werther K, de Freitas Raso T, Mendes-Giannini MJ, Zaragoza O, Fusco-Almeida AM.

Front Microbiol. 2016 Feb 16;7:153. doi: 10.3389/fmicb.2016.00153. eCollection 2016. Erratum in: Front Microbiol. 2016;7:537.

27.

Cell Wall Changes in Amphotericin B-Resistant Strains from Candida tropicalis and Relationship with the Immune Responses Elicited by the Host.

Mesa-Arango AC, Rueda C, Román E, Quintin J, Terrón MC, Luque D, Netea MG, Pla J, Zaragoza O.

Antimicrob Agents Chemother. 2016 Mar 25;60(4):2326-35. doi: 10.1128/AAC.02681-15. Print 2016 Apr.

28.

Role of Cln1 during melanization of Cryptococcus neoformans.

García-Rodas R, Trevijano-Contador N, Román E, Janbon G, Moyrand F, Pla J, Casadevall A, Zaragoza O.

Front Microbiol. 2015 Aug 12;6:798. doi: 10.3389/fmicb.2015.00798. eCollection 2015.

29.

The formation of titan cells in Cryptococcus neoformans depends on the mouse strain and correlates with induction of Th2-type responses.

García-Barbazán I, Trevijano-Contador N, Rueda C, de Andrés B, Pérez-Tavárez R, Herrero-Fernández I, Gaspar ML, Zaragoza O.

Cell Microbiol. 2016 Jan;18(1):111-24. doi: 10.1111/cmi.12488. Epub 2015 Sep 6.

PMID:
26243235
30.

A simple prediction score for estimating the risk of candidaemia caused by fluconazole non-susceptible strains.

Cuervo G, Puig-Asensio M, Garcia-Vidal C, Fernández-Ruiz M, Pemán J, Nucci M, Aguado JM, Salavert M, González-Romo F, Guinea J, Zaragoza O, Gudiol C, Carratalà J, Almirante B; CANDIPOP Project; Validation Cohort Project.

Clin Microbiol Infect. 2015 Jul;21(7):684.e1-9. doi: 10.1016/j.cmi.2015.02.029. Epub 2015 Mar 10.

31.

Cryptococcus neoformans induces antimicrobial responses and behaves as a facultative intracellular pathogen in the non mammalian model Galleria mellonella.

Trevijano-Contador N, Herrero-Fernández I, García-Barbazán I, Scorzoni L, Rueda C, Rossi SA, García-Rodas R, Zaragoza O.

Virulence. 2015;6(1):66-74. doi: 10.4161/21505594.2014.986412.

32.

Distinct and redundant roles of exonucleases in Cryptococcus neoformans: implications for virulence and mating.

Wollschlaeger C, Trevijano-Contador N, Wang X, Legrand M, Zaragoza O, Heitman J, Janbon G.

Fungal Genet Biol. 2014 Dec;73:20-8. doi: 10.1016/j.fgb.2014.09.007. Epub 2014 Sep 28.

33.

The production of reactive oxygen species is a universal action mechanism of Amphotericin B against pathogenic yeasts and contributes to the fungicidal effect of this drug.

Mesa-Arango AC, Trevijano-Contador N, Román E, Sánchez-Fresneda R, Casas C, Herrero E, Argüelles JC, Pla J, Cuenca-Estrella M, Zaragoza O.

Antimicrob Agents Chemother. 2014 Nov;58(11):6627-38. doi: 10.1128/AAC.03570-14. Epub 2014 Aug 25.

34.

Capsule growth in Cryptococcus neoformans is coordinated with cell cycle progression.

García-Rodas R, Cordero RJ, Trevijano-Contador N, Janbon G, Moyrand F, Casadevall A, Zaragoza O.

MBio. 2014 Jun 17;5(3):e00945-14. doi: 10.1128/mBio.00945-14.

35.

Emerging Trichosporon asahii in elderly patients: epidemiological and molecular analysis by the DiversiLab system.

Treviño M, García-Riestra C, Areses P, García X, Navarro D, Suárez FJ, López-Dequidt IA, Zaragoza O, Cuenca-Estrella M.

Eur J Clin Microbiol Infect Dis. 2014 Sep;33(9):1497-503. doi: 10.1007/s10096-014-2099-6. Epub 2014 Apr 10.

PMID:
24718613
36.

Expanding the use of alternative models to investigate novel aspects of immunity to microbial pathogens.

Trevijano-Contador N, Zaragoza O.

Virulence. 2014 May 15;5(4):454-6. doi: 10.4161/viru.28775. Epub 2014 Apr 9. No abstract available.

37.

A multiplex real-time PCR assay for identification of Pneumocystis jirovecii, Histoplasma capsulatum, and Cryptococcus neoformans/Cryptococcus gattii in samples from AIDS patients with opportunistic pneumonia.

Gago S, Esteban C, Valero C, Zaragoza O, Puig de la Bellacasa J, Buitrago MJ.

J Clin Microbiol. 2014 Apr;52(4):1168-76. doi: 10.1128/JCM.02895-13. Epub 2014 Jan 29.

38.

Molecular identification and antifungal susceptibility of yeast isolates causing fungemia collected in a population-based study in Spain in 2010 and 2011.

Guinea J, Zaragoza Ó, Escribano P, Martín-Mazuelos E, Pemán J, Sánchez-Reus F, Cuenca-Estrella M; CANDIPOP Project, GEIH-GEMICOMED (SEIMC), and REIPI.

Antimicrob Agents Chemother. 2014;58(3):1529-37. doi: 10.1128/AAC.02155-13. Epub 2013 Dec 23.

39.

Paradoxical growth of Candida albicans in the presence of caspofungin is associated with multiple cell wall rearrangements and decreased virulence.

Rueda C, Cuenca-Estrella M, Zaragoza O.

Antimicrob Agents Chemother. 2014;58(2):1071-83. doi: 10.1128/AAC.00946-13. Epub 2013 Dec 2.

40.

Epidemiology and predictive factors for early and late mortality in Candida bloodstream infections: a population-based surveillance in Spain.

Puig-Asensio M, Padilla B, Garnacho-Montero J, Zaragoza O, Aguado JM, Zaragoza R, Montejo M, Muñoz P, Ruiz-Camps I, Cuenca-Estrella M, Almirante B; CANDIPOP Project; GEIH-GEMICOMED (SEIMC); REIPI.

Clin Microbiol Infect. 2014 Apr;20(4):O245-54. doi: 10.1111/1469-0691.12380. Epub 2013 Oct 11.

41.

Comparison between the EUCAST procedure and the Etest for determination of the susceptibility of Candida species isolates to micafungin.

Marcos-Zambrano LJ, Escribano P, Rueda C, Zaragoza Ó, Bouza E, Guinea J.

Antimicrob Agents Chemother. 2013 Nov;57(11):5767-70. doi: 10.1128/AAC.01032-13. Epub 2013 Aug 26. Erratum in: Antimicrob Agents Chemother. 2016 Jul;60(7):4429.

42.

Candida tropicalis antifungal cross-resistance is related to different azole target (Erg11p) modifications.

Forastiero A, Mesa-Arango AC, Alastruey-Izquierdo A, Alcazar-Fuoli L, Bernal-Martinez L, Pelaez T, Lopez JF, Grimalt JO, Gomez-Lopez A, Cuesta I, Zaragoza O, Mellado E.

Antimicrob Agents Chemother. 2013 Oct;57(10):4769-81. doi: 10.1128/AAC.00477-13. Epub 2013 Jul 22.

43.

Titan cells in Cryptococcus neoformans: cells with a giant impact.

Zaragoza O, Nielsen K.

Curr Opin Microbiol. 2013 Aug;16(4):409-13. doi: 10.1016/j.mib.2013.03.006. Epub 2013 Apr 12.

44.

Antifungal efficacy during Candida krusei infection in non-conventional models correlates with the yeast in vitro susceptibility profile.

Scorzoni L, de Lucas MP, Mesa-Arango AC, Fusco-Almeida AM, Lozano E, Cuenca-Estrella M, Mendes-Giannini MJ, Zaragoza O.

PLoS One. 2013;8(3):e60047. doi: 10.1371/journal.pone.0060047. Epub 2013 Mar 28.

45.

Galleria mellonella as a model host to study Paracoccidioides lutzii and Histoplasma capsulatum.

Thomaz L, García-Rodas R, Guimarães AJ, Taborda CP, Zaragoza O, Nosanchuk JD.

Virulence. 2013 Feb 15;4(2):139-46. doi: 10.4161/viru.23047. Epub 2013 Jan 9.

46.

The non-mammalian host Galleria mellonella can be used to study the virulence of the fungal pathogen Candida tropicalis and the efficacy of antifungal drugs during infection by this pathogenic yeast.

Mesa-Arango AC, Forastiero A, Bernal-Martínez L, Cuenca-Estrella M, Mellado E, Zaragoza O.

Med Mycol. 2013 Jul;51(5):461-72. doi: 10.3109/13693786.2012.737031. Epub 2012 Nov 21.

PMID:
23170962
47.

It only takes one to do many jobs: Amphotericin B as antifungal and immunomodulatory drug.

Mesa-Arango AC, Scorzoni L, Zaragoza O.

Front Microbiol. 2012 Aug 8;3:286. eCollection 2012.

48.

Recurrent episodes of candidemia due to Candida glabrata with a mutation in hot spot 1 of the FKS2 gene developed after prolonged therapy with caspofungin.

Durán-Valle MT, Gago S, Gómez-López A, Cuenca-Estrella M, Jiménez Díez-Canseco L, Gómez-Garcés JL, Zaragoza O.

Antimicrob Agents Chemother. 2012 Jun;56(6):3417-9. doi: 10.1128/AAC.06100-11. Epub 2012 Mar 5.

49.

Catch me if you can: phagocytosis and killing avoidance by Cryptococcus neoformans.

García-Rodas R, Zaragoza O.

FEMS Immunol Med Microbiol. 2012 Mar;64(2):147-61. doi: 10.1111/j.1574-695X.2011.00871.x. Review.

50.

Multiple Disguises for the Same Party: The Concepts of Morphogenesis and Phenotypic Variations in Cryptococcus neoformans.

Zaragoza O.

Front Microbiol. 2011 Sep 6;2:181. doi: 10.3389/fmicb.2011.00181. eCollection 2011.

Supplemental Content

Loading ...
Support Center